The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes

References

• Tsai HC, Tzeng HE, Huang CY, et al. WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma. Cell Death Dis. 2017;8:e2750.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Tomihara K, Tachinami H, et al. Conventional osteosarcoma of the mandible successfully treated with radical surgery and adjuvant chemotherapy after responding poorly to neoadjuvant chemotherapy: a case report. J Med Case Rep. 2017;11:210.
   PubMedGoogle Scholar
• Haghiralsadat F, Amoabediny G, Naderinezhad S, et al. Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. Int J Nanomed. 2018;13:3853–3866.
   PubMed Web of Science ®Google Scholar
• Magalhães M, Almeida M, Tavares-da-Silva E, et al. miR-145-loaded micelleplexes as a novel therapeutic strategy to inhibit proliferation and migration of osteosarcoma cells. Eur J Pharm Sci. 2018;123:28–42.
   PubMed Web of Science ®Google Scholar
• Dragomir M, Chen B, Calin GA. Exosomal lncRNAs as new players in cell-to-cell communication. Transl Cancer Res. 2018;7:S243–S252.
   PubMed Web of Science ®Google Scholar
• Deng F, Zhang X, Wang W, et al. Identification of Gossypium hirsutum long non-coding RNAs (lncRNAs) under salt stress. BMC Plant Biol. 2018;18:23.
   PubMed Web of Science ®Google Scholar
• Rathinasamy B, Velmurugan BK. Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals. Biomed Pharmacother. 2018;102:242–248.
   PubMed Web of Science ®Google Scholar
• Song X, Luo X, Gao Q, et al. Dysregulation of LncRNAs in placenta and pathogenesis of preeclampsia. Curr Drug Targets. 2017;18:1165–1170.
   PubMed Web of Science ®Google Scholar
• Gioia R, Drouin S, Ouimet M, et al. LncRNAs downregulated in childhood acute lymphoblastic leukemia modulate apoptosis, cell migration, and DNA damage response. Oncotarget. 2017;8:80645–80650.
   PubMedGoogle Scholar
• Ma SC, Li Q, Peng JY, et al. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood brain barrier permeability in tumor brain metastasis. Oncol Rep. 2018;39:1441–1453.
   PubMed Web of Science ®Google Scholar
• Duguang L, Jin H, Xiaowei Q, et al. The involvement of lncRNAs in the development and progression of pancreatic cancer. Cancer Biol Ther. 2017;18:927–936.
   PubMed Web of Science ®Google Scholar
• Xie J, Lin D, Lee DH, et al. Copy number analysis identifies tumor suppressive lncRNAs in human osteosarcoma. Int J Oncol. 2017;50:863–872.
   PubMed Web of Science ®Google Scholar
• Grossi E, Sánchez Y, Huarte M. Expanding the p53 regulatory network: LncRNAs take up the challenge. Biochim Biophys Acta. 2016;1859:200–208.
   PubMed Web of Science ®Google Scholar
• Wan X, Ding X, Chen S, et al. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumor Biol. 2015;36:521–532.
   PubMedGoogle Scholar
• Xiong Y, Wang T, Wang M, et al. Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2018;9:11377–11386.
   PubMedGoogle Scholar
• Wu J, Hann SS. Functions and roles of long-non-coding RNAs in human nasopharyngeal carcinoma. Cell Physiol Biochem. 2018;45:1191–1204.
   PubMed Web of Science ®Google Scholar
• Tang J, Zhuo H, Zhang X, et al. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death Dis. 2014;5:e1549.
   PubMed Web of Science ®Google Scholar
• Wu H, He Y, Chen H, et al. LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio. 2019;9:781–790.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yin L, Li H, et al. The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis. Cancer Biol Ther. 2019;12:1–8.
   Google Scholar
• Dong Y, Liang G, Yuan B, et al. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol. 2015;36:1477–1486.
   PubMed Web of Science ®Google Scholar
• Ren T, Piperdi S, Koirala P, et al. CD49b inhibits osteogenic differentiation and plays an important role in osteosarcoma progression. Oncotarget. 2017;8:87848–87859.
   PubMedGoogle Scholar
• Krishnamurthy A, Arulmolichelvan A. The management challenges in an unusual case of primary osteosarcoma of the rib in an adult patient. Indian J Surg. 2017;79:363–366.
   PubMed Web of Science ®Google Scholar
• Coventon J. A review of the mechanism of action and clinical applications of sorafenib in advanced osteosarcoma. J Bone Oncol. 2017;8:4–7.
   PubMed Web of Science ®Google Scholar
• Park SH, Lee J, Kang MA, et al. Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway. Oncol Lett. 2018;15:9687–9696.
   PubMed Web of Science ®Google Scholar
• Zou H, Wu LX, Yang Y, et al. lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients. Oncotarget. 2017;8:78767–78780.
   PubMedGoogle Scholar
• Li S, Chen X, Liu X, et al. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. Oral Oncol. 2017;73:1–9.
   PubMed Web of Science ®Google Scholar
• Pasic I, Shlien A, Durbin AD, et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res. 2010;70:160–171.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Geng PL, Yin P, et al. Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J Cancer Prev. 2013;14:2311–2315.
   PubMedGoogle Scholar
• Liu Q, Huang J, Zhou N, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013;41:4976–4987.
   PubMed Web of Science ®Google Scholar
• Li JP, Liu LH, Li J, et al. Microarray expression profile of long noncoding RNAs in human osteosarcoma. Biochem Biophys Res Commun. 2013;433:200–206.
   PubMed Web of Science ®Google Scholar
• Kiaei A, Onsori H, Alijani A, et al. Detection of t(8;14) c-myc/IgH gene rearrangement by long-distance polymerase chain reaction in patients with diffuse large B-cell lymphoma. Hematol Oncol Stem Cell Ther. 2016;9:141–146.
   PubMedGoogle Scholar
• Melis MHM, Nevedomskaya E, van Burgsteden J, et al. The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model. Oncotarget 2017;8:93867–93877.
   PubMedGoogle Scholar
• Lombardi O, Varshney D, Phillips NM, et al. c-Myc deregulation induces mRNA capping enzyme dependency. Oncotarget. 2016;7:82273–82288.
   PubMedGoogle Scholar
• Yang F, Xue X, Bi J, et al. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol. 2013;139:437–445.
   PubMed Web of Science ®Google Scholar
• He X, Tan X, Wang X, et al. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol. 2014;35:12181–12188.
   PubMedGoogle Scholar
• Yang F, Xue X, Zheng L, et al. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability. FEBS J. 2014;281:802–813.
   PubMed Web of Science ®Google Scholar
• Zhang EB, Han L, Yin DD, et al. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol. 2014;31:914.
   PubMed Web of Science ®Google Scholar
• Hu G, Lou Z, Gupta M. The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation. PLoS One. 2014;9:e107016.
   PubMed Web of Science ®Google Scholar
• Liao LM, Sun XY, Liu AW, et al. Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer. Gynecol Oncol. 2014;133:616–623.
   PubMed Web of Science ®Google Scholar
• Yan CH, Li F, Ma YC. Plumbagin shows anticancer activity in human osteosarcoma (MG-63) cells via the inhibition of S-Phase checkpoints and down-regulation of c-myc. Int J Clin Exp Med. 2015;8:14432–14439.
   PubMed Web of Science ®Google Scholar